1-GOLD-22-Home-Banner-Template-1584-x-396.jpg
  • LinkedIn
  • Black YouTube Icon

NEW ISSUE OF GOLD 

OUT NOW! 

Immerse yourself in the latest edition of GOLD! From methods of tackling antimicrobial resistance to examining what companies can do to help patients in a war zone, this issue of GOLD explores some of the latest conquests and concerns within the pharmaceutical industry.

+
Read Now
 
View our Editor's Picks

Catalyst of pharma 

Claus Zieler

Claus Zieler, President, Established Markets, Astellas tells GOLD about creating a winning company culture, crisis management and his passion for cell and gene therapies.

GOLD-22-catalyst-Claus-Zieler-Astellas.jpg

Cover feature

Time to
tackle AMR

GOLD-22-time-to-tackle-AMR-superbugs-antibiotics.jpg

How is the pharmaceutical industry responding to the public health crisis of antimicrobial resistance?

 
 

Editor's Picks

People

Reverse mentoring:
a how-to guide
GOLD-22-reverse-mentoring.jpg

Reverse mentoring schemes defy tradition but can deliver clear results. This how-to guide offers hints and tips for companies looking to set up these initiatives.

+ Read now

Patients 

Roundtable | The progress and pain points of patient centricity 
GOLD-22-roundtable-patient-advocacy-Trishna-Bhardia-Laurence-Woollard-2.jpg

Patient centricity is a key focus for pharma, but is it executing this objective effectively? GOLD asks two patients advocates to share their thoughts. 

+ Read now

International

Pharma in
Brazil
GOLD-22-pharma-in-Brazil.jpg

GOLD journeys to the shores of Brazil to examine its pharmaceutical landscape and consider its response to COVID-19, access challenges and more.

+ Read now
 

Infographic

Access to medicine
in Latin America

Explore how the pharmaceutical industry’s R&D productivity is
steadily improving…

infographic_22.jpg

​

WE TALK TO...

GOLD Podcast

Claire Gillis
International CEO, WPP Health Practice
We sit down with Claire Gillis, who discusses how the communications role can transform patient outcomes.
 

GOLD Podcast

Pierre Bourdage
Global Head Biopharmaceuticals, Sandoz
Pierre Bourdage provides insight into the state and future of the biosimilars market and discusses how to adapt to ‘the new normal'.

GOLD Podcast

Mircea Cubillos
Vice President Hematology EMEA, Commercial Strategy Lead, Janssen
Mircea Cubillos discusses progression in oncology during COVID-19, and cultivating healthy habits during lockdown.

GOLD Podcast

Dr Steve Ingham
Performance Scientist and Consultant
Dr Steve Ingham, Olympic Performance Scientist and Specialist speaks about adapting to setbacks and being resilient.

Never miss a GOLD update, subscribe! 

Subscribe now